Granahan Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.4M | Buy |
|
|||||
|
2022
Q2 | $3.02M | Sell |
|
|||||
|
2022
Q1 | $5.78M | Buy |
|
|||||
|
2021
Q4 | $3.6M | Buy |
|
|||||
|
2021
Q3 | $5.07M | Sell |
|
|||||
|
2021
Q2 | $8.3M | Buy |
|
|||||
|
2021
Q1 | $5.88M | Sell |
|
|||||
|
2020
Q4 | $8.76M | Buy |
|
|||||
|
2020
Q3 | $3.29M | Sell |
|
|||||
|
2020
Q2 | $3.21M | Buy |
|
|||||
|
2020
Q1 | $1.45M | Sell |
|
|||||
|
2019
Q4 | $2.11M | Hold |
|
|||||
|
2019
Q3 | $1.42M | Buy |
|
|||||
|
2019
Q2 | $1.5M | Sell |
|
|||||
|
2019
Q1 | $1.17M | Sell |
|
|||||
|
2018
Q4 | $1M | Sell |
|
|||||
|
2018
Q3 | $2.1M | Sell |
|
|||||
|
2018
Q2 | $5.57M | Buy |
|
|||||
|
2018
Q1 | $3.96M | Sell |
|
|||||
|
2017
Q4 | $3.31M | Sell |
|
|||||
|
2017
Q3 | $4.71M | Buy |
|
|||||
|
2017
Q2 | $2.79M | Buy |
|